Quantcast

Latest Estrogens Stories

2014-08-21 12:30:21

DUBLIN, Ireland, August 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone) has announced the addition of the "Global Hormone Replacement Therapy Market 2014-2018" [http://www.researchandmarkets.com/research/3zh3q8/global_hormone ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Hormone replacement therapy, also known as hormone therapy, is a means of replacing...

2014-08-05 23:06:47

JDS Therapeutics Announces U.S. Launch of Physician Recommended Relizen®, a Safe, Natural Therapy for Hot Flashes Los Angeles (PRWEB) August 05, 2014 Relizen®†, a patented, non-hormonal nutritional supplement for the relief of hot flashes associated with menopause, is now available to U.S. consumers for purchase at Relizen.com. Over 43 million women are of menopausal age in the United States. Seventy-five percent of women report experiencing hot flashes, and 87 percent of...

2014-07-15 16:25:16

NEW YORK, July 15, 2014 /PRNewswire/ -- According to BCC Research, the global market for women's health therapeutics is expected to reach $22.5 billion in 2018. Due to a variety of factors, such as an aging worldwide population, an increasing awareness among patients and physicians, the introduction of new therapies into the market, and the overall disease pattern and treatment differences between men and women, this market is expected to grow at a CAGR of 3.5% over the next five...

2014-06-18 12:34:08

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Hormone Replacement Therapy (HRT) Industryhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/hormone_replacement_therapy_hrt.html This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and...

2014-05-29 20:22:54

New offering through an agreement with Meda AB expands Mission's women's healthcare options SAN ANTONIO, May 29, 2014 /PRNewswire/ -- Mission Pharmacal Company has begun exclusive promotion of Elestrin® (estradiol gel) 0.06% in the United States through an agreement with Meda AB. Elestrin is a prescription medicine approved by the Food and Drug Administration (FDA) for use as a topical hormone replacement gel to treat moderate-to-severe hot flashes due to menopause. Using estrogen-alone may...

2014-04-04 08:25:40

NORTHRIDGE, Calif., April 4, 2014 /PRNewswire-USNewswire/ -- A daily dose of S-equol (13.1 mg), delivered via a fermented soy germ-based nutritional supplement to manage menopause symptoms, showed no impact on reproductive or thyroid hormones or the menstrual cycles of premenopausal women, according to a peer-reviewed study reported in a poster at the Academy of Women's Health 2014 annual meeting in Washington, DC. Previous controlled clinical trials documented that daily doses of...

2014-03-24 16:24:14

MAPLE GROVE, Minn., March 24, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to the development of new treatments for diseases of the central nervous system (CNS), today announced that it has entered into a definitive agreement under which New Jersey-based Vertical Pharmaceuticals, LLC has acquired Upsher-Smith's rights to Divigel(®) (estradiol gel) 0.1%, Nexa(®) Plus Rx Prenatal Vitamin, and Provella(®), a...

2014-03-24 16:24:09

Avista Capital Partners-Backed Company to Continue Add-On Acquisition Strategy SAYREVILLE, N.J., March 24, 2014 /PRNewswire/ -- Vertical Pharmaceuticals, LLC, a wholly owned subsidiary of Vertical / Trigen Holdings, LLC ("Vertical / Trigen"), today announced that it has acquired the rights to three branded women's health products from Upsher-Smith Laboratories, Inc. The terms of the transaction were not disclosed. Vertical / Trigen is a portfolio company of Avista Capital Partners....

2014-03-13 17:07:09

When initiated soon after menopause, hormone therapy with estradiol prevented degeneration in key brain regions of women who were at heightened dementia risk, according to a new study led by Stanford University School of Medicine researchers. The investigators also found that another type of hormone therapy, marketed under the brand name Premarin, was far less protective. Premarin is a mixture of 30-plus substances derived from the urine of pregnant mares. Estradiol — the dominant...

Cognition, Mood Changes Not Linked To Postmenopausal Estrogen Loss
2013-11-26 08:39:49

April Flowers for redOrbit.com - Your Universe Online Decreased estrogen levels after menopause are largely unrelated to changes in cognitive ability and mood, according to a new study led by Stanford University School of Medicine. The study, published in Proceedings of the National Academy of Sciences (PNAS), found a possible link between levels of progesterone and cognition among younger postmenopausal women, however. First to investigate associations between sex hormones and...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'